HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)
Key Information
Due Date: June 17, 2025
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant, Government
Match Required: No
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
The program's goal is to develop treatments that utilize credible neural targets for device-based interventions and diagnostics for pain. This will draw on recent knowledge about the anatomy and physiology of pain-related pathways. Areas of focus include the central, spinal, and peripheral systems.
Grant activities will help push the development of these new devices forward, bringing them up to the point where they are ready for first tests in human clinical trials. This will be achieved by addressing and overcoming key challenges that have been identified during initial proof-of-concept studies.
The program's scope includes the development and optimization of technology, as well as studies to prepare these devices for approval for human use.
Key Dates
Open Date: August 23, 2022
Application Due Date: June 17, 2025
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses